Valuation: i-SENS, Inc.

Capitalization 470B 327M 312M 293M 260M 463M 28.28B 514M 3.5B 1.3B 11.82B 1.22B 1.2B 49.84B P/E ratio 2024 *
39.5x
P/E ratio 2025 * 35.8x
Enterprise value 590M 410K 391K 368K 326K 581K 35.48M 645K 4.39M 1.63M 14.83M 1.54M 1.5M 62.53M EV / Sales 2024
1.45x
EV / Sales 2025 * 1.86x
Free-Float
-
Yield 2024 *
0.59%
Yield 2025 * 0.59%
More valuation ratios * Estimated data
Dynamic Chart
I-SENS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 Nov. 13 CI
Kwang Dong Pharmaceutical Co., Ltd. completed the acquisition of 29.7% stake in Precision Biosensor, Inc. from i-SENS, Inc. from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo. 24-10-01 CI
I-SENS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 24-08-14 CI
Kwang Dong Pharmaceutical Co., Ltd. agreed to acquire 29.7% stake in Precision Biosensor, Inc. from i-SENS, Inc. from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo for KRW 16.9 billion. 24-07-01 CI
I-SENS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 24-05-12 CI
I-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd 24-04-29 CI
I-SENS, Inc. announced that it expects to receive KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd 24-04-25 CI
I-SENS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 24-03-20 CI
I-SENS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 23-11-14 CI
I-SENS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 23-08-11 CI
I-SENS, Inc. completed the acquisition of AgaMatrix, Inc. 23-06-22 CI
I-SENS, Inc. agreed to acquire AgaMatrix, Inc. for $20 million. 23-05-15 CI
I-SENS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 23-05-14 CI
More news
1 day-1.76%
1 week-9.24%
Current month-7.48%
1 month+4.18%
3 months-12.57%
6 months-2.85%
Current year+9.36%
More quotes
1 week
16 700.00
Extreme 16700
18 500.00
1 month
15 810.00
Extreme 15810
19 300.00
Current year
14 880.00
Extreme 14880
19 300.00
1 year
14 520.00
Extreme 14520
23 750.00
3 years
12 950.00
Extreme 12950
39 700.00
5 years
7 500.00
Extreme 7500
39 700.00
10 years
7 500.00
Extreme 7500
39 700.00
More quotes
Director TitleAgeSince
Chief Executive Officer 65 -
Chief Executive Officer 70 2000-05-03
Chief Tech/Sci/R&D Officer - -
Manager TitleAgeSince
Director/Board Member 70 2000-05-03
Director/Board Member 65 2000-05-03
Director/Board Member 52 -
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-1.76%-9.24%-25.61%+23.70% 327M
-0.01%+0.01%+41.67%+119.19% 12.57B
-1.55%+3.07%-1.64%+16.02% 10.31B
+0.96%+2.92%+35.16%-20.77% 9.71B
+0.95%+0.05%+7.03%-40.18% 5.41B
+1.61%-0.19%-0.61%+20.68% 5.16B
-1.00%+0.23%+19.56%+162.50% 4.97B
0.00%+0.21%+35.41%-0.03% 4.69B
-0.80%+0.10%-12.72%+38.55% 4.55B
+3.55%+1.03%+41.12%-73.36% 2.43B
Average +0.19%+0.06%+13.94%+24.63% 6.01B
Weighted average by Cap. +0.10%+1.28%+19.63%+35.98%
See all sector performances

Financials

2024 2025 *
Net sales 285B 198M 189M 178M 157M 281M 17.14B 312M 2.12B 786M 7.17B 742M 727M 30.21B 331B 230M 220M 207M 183M 326M 19.93B 362M 2.47B 914M 8.33B 862M 845M 35.12B
Net income 11.9B 8.27M 7.89M 7.43M 6.57M 11.72M 716M 13.02M 88.61M 32.82M 299M 30.98M 30.36M 1.26B 13.1B 9.1M 8.69M 8.17M 7.23M 12.9M 788M 14.33M 97.54M 36.13M 329M 34.1M 33.42M 1.39B
Net Debt 120B 83.19M 79.36M 74.69M 66.07M 118M 7.2B 131M 891M 330M 3.01B 312M 305M 12.69B 144B 100M 95.8M 90.17M 79.76M 142M 8.69B 158M 1.08B 399M 3.63B 376M 369M 15.32B
More financial data * Estimated data
Logo i-SENS, Inc.
i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
Employees
845
More about the company
Date Price Change Volume
25-02-14 17,010.00 +1.86% 112,987
25-02-13 16,700.00 -1.76% 130,760
25-02-12 17,000.00 +0.18% 118,807
25-02-11 16,970.00 -4.29% 298,479
25-02-10 17,730.00 -4.42% 154,475

End-of-day quote Korea S.E., February 12, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
17,010.00KRW
Average target price
33,000.00KRW
Spread / Average Target
+94.00%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A099190 Stock